These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 34585633)
1. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome. Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633 [TBL] [Abstract][Full Text] [Related]
2. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835 [TBL] [Abstract][Full Text] [Related]
3. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts. Weng L; Li L; Zhao K; Xu T; Mao Y; Shu H; Chen X; Chen J; Wu J; Guo X; Tu J; Zhang D; Sun W; Kong X Cardiovasc Drugs Ther; 2022 Jun; 36(3):413-424. PubMed ID: 35156147 [TBL] [Abstract][Full Text] [Related]
4. piR112710 attenuates diabetic cardiomyopathy through inhibiting Txnip/NLRP3-mediated pyroptosis in db/db mice. Jiao A; Liu H; Wang H; Yu J; Gong L; Zhang H; Fu L Cell Signal; 2024 Oct; 122():111333. PubMed ID: 39102928 [TBL] [Abstract][Full Text] [Related]
5. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells. Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Xu D; Zhang X; Chen X; Yang S; Chen H Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396 [TBL] [Abstract][Full Text] [Related]
7. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Li X; Li Z; Li B; Zhu X; Lai X Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy. Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation. Hashiesh HM; Azimullah S; Nagoor Meeran MF; Saraswathiamma D; Arunachalam S; Jha NK; Sadek B; Adeghate E; Sethi G; Albawardi A; Al Marzooqi S; Ojha S J Pharmacol Exp Ther; 2024 Oct; 391(2):241-257. PubMed ID: 38955492 [TBL] [Abstract][Full Text] [Related]
11. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180 [TBL] [Abstract][Full Text] [Related]
12. Formononetin ameliorates myocardial ischemia/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway. Wang DS; Yan LY; Yang DZ; Lyu Y; Fang LH; Wang SB; Du GH Biochem Biophys Res Commun; 2020 May; 525(3):759-766. PubMed ID: 32145915 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031 [TBL] [Abstract][Full Text] [Related]
14. Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway. Yao R; Cao Y; Wang C; Xu L; Zhang X; Deng Y; Li F; Wang S BMC Complement Med Ther; 2021 Feb; 21(1):78. PubMed ID: 33637069 [TBL] [Abstract][Full Text] [Related]
15. Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury. Wang J; Li Y; Li L; Liang H; Ye H; Kang P; Li Z; Yu Y; Gao Q BMC Cardiovasc Disord; 2024 Jul; 24(1):351. PubMed ID: 38987672 [TBL] [Abstract][Full Text] [Related]
17. Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy. Sun X; Sun X; Meng H; Wu J; Guo X; Du L; Wu H Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057549 [TBL] [Abstract][Full Text] [Related]
18. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways. Yao J; Li Y; Jin Y; Chen Y; Tian L; He W Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494 [TBL] [Abstract][Full Text] [Related]
19. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation. Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627 [TBL] [Abstract][Full Text] [Related]